ArticleFrontiers in nutrition2025
Maternal supplementation with chia oil attenuates hepatic metabolic disturbances in mice subjected to postnatal undernutrition.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early postnatal undernutrition, leading to impaired growth and low body weight, has been associated with enduring metabolic alterations that may persist into adulthood. We proposed that plant-based ω-3 fatty acids, as in maternal supplementation, attenuate metabolic alterations induced by postnatal dietary restriction, such as glucose disturbances and oxidative stress. Methods: To test this, we investigated the effects of maternal supplementation with two distinct doses of Chia Oil (ChO) (2.5 or 5 g/kg body mass) on metabolic parameters in BALB/c mice subjected to postnatal undernutrition. The undernutrition model was created by increasing the litter size to 15-16 pups, forming the undernutrition (UN) group. These UN groups received maternal ChO supplementation at 2.5 g/kg or 5 g/kg b.m., labeled as UN2.5 and UN5, respectively. Results: By day 21, the UN5 group showed less weight gain compared to the UN2.5 group. At 120 days, glucose tolerance tests revealed a lower area under the curve in both supplemented groups compared to the UN animals. A maternal dose of 5 g/kg b.m. of ChO was linked to more favorable oxidative stress markers, suggesting this effect is not due to changes in antioxidant enzymes like superoxide dismutase and catalase, which remained stable in the liver tissue in this model. This dose provided a slight benefit in reducing metabolic changes, with the UN5 group showing lower total hepatic lipid levels. Additionally, histopathological analysis of the tissue revealed no alterations in the experimental groups. Conclusion: These observations suggest a protective role of maternal ChO supplementation at a dose of 5 g/kg b.w. against metabolic impairments induced by postnatal undernutrition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.